CTI BioPharma
CTIC
#5637
Rank
$1.19 B
Marketcap
$9.09
Share price
0.00%
Change (1 day)
30.79%
Change (1 year)

Market capitalization of CTI BioPharma (CTIC)

Last known market cap: $1.19 Billion USD

On August 25, 2023 CTI BioPharma had a market cap of $1.19 Billion USD. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CTI BioPharma from 2001 to 2023

End of year Market Cap

Year Marketcap Change
2023$1.19 B57.19%
2022$0.76 B218.03%
2021$0.23 B-1.88%
2020$0.24 B166.78%
2019$91.6 M115.35%
2018$42.53 M-63.06%
2017$0.11 B0.08%
2016$0.11 B-66.65%
2015$0.34 B-17.31%
2014$0.41 B50.1%
2013$0.27 B94.66%
2012$0.14 B-36.15%
2011$0.22 B-24.72%
2010$0.29 B-55.86%
2009$0.67 B8121.38%
2008$8.18 M-91.53%
2007$96.63 M-61.82%
2006$0.25 B61.62%
2005$0.15 B-68.47%
2004$0.49 B68.55%
2003$0.29 B24.03%
2002$0.23 B-70.83%
2001$0.81 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
$170.26 B 14,102.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$104.05 B 8,580.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
$18.56 B 1,448.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$9.32 B 678.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$890.83 B 74,211.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$33.60 B 2,703.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
$251.76 B 20,901.58%๐Ÿ‡จ๐Ÿ‡ญ Switzerland